Takeda Pharmaceutical (TAK) Revenue (2017 - 2026)
Takeda Pharmaceutical (TAK) posted Revenue of $7.65 billion for the quarter ended Jun 30, 2026, up 0.1% from $7.65 billion a year earlier but down 1.6% from the prior quarter.
Powered by 
Analysis
Takeda Pharmaceutical (TAK) Revenue (2017 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Revenue at Takeda Pharmaceutical was $46.49 billion, up 0.7% year-over-year; for the year ended Mar 31, 2026, it was $29.93 billion, down 0.5% from the prior year.
- Annual Revenue shows a five-year compound annual growth rate of -0.2% (years ended Mar 2021 to Mar 2026).
- In prior years, Takeda Pharmaceutical's Revenue was $30.08 billion in the year ended Mar 31, 2025 (+1.7%), $29.57 billion in the year ended Mar 31, 2024 (-0.8%), $29.81 billion in the year ended Mar 31, 2023 (-6.2%) and $31.79 billion in the year ended Mar 31, 2022 (+5.4%).
- Quarterly Revenue has run from a low of $6.93 billion in the quarter ended Dec 31, 2024 to a high of $23.95 billion in the quarter ended Sep 30, 2025 over five years.
- On a year-over-year basis, Revenue increased in four of the last eight quarters, with growth averaging 0.2%.
- The strongest year-over-year quarter for Revenue in the past five years was the quarter ended Sep 30, 2023, with growth of 206.6%; the weakest was the quarter ended Dec 31, 2023, with a decline of 8.4%.
- According to Business Quant data, Revenue for the three prior quarters was $7.78 billion (quarter ended Mar 31, 2026), $7.11 billion (quarter ended Dec 31, 2025) and $23.95 billion (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 3.33 Bn |
| 10 | Takeda Pharmaceutical | 2.68 Bn | -23.83 Bn | 5.10 Bn | 7.65 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.65 Bn |
| Mar 31, 2026 | 7.78 Bn |
| Dec 31, 2025 | 7.11 Bn |
| Sep 30, 2025 | 23.95 Bn |
| Jun 30, 2025 | 7.65 Bn |
| Mar 31, 2025 | 7.92 Bn |
| Dec 31, 2024 | 6.93 Bn |
| Sep 30, 2024 | 23.65 Bn |
| Jun 30, 2024 | 7.76 Bn |
| Mar 31, 2024 | 8.15 Bn |
| Dec 31, 2023 | 7.11 Bn |
| Sep 30, 2023 | 22.25 Bn |
| Jun 30, 2023 | 7.72 Bn |
| Mar 31, 2023 | 8.00 Bn |
| Dec 31, 2022 | 7.76 Bn |
| Sep 30, 2022 | 7.26 Bn |
| Jun 30, 2022 | 7.52 Bn |
| Mar 31, 2022 | 8.37 Bn |
| Jun 30, 2021 | 8.67 Bn |
| Mar 31, 2021 | 7.28 Bn |
API Access
Takeda Pharmaceutical Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=TAK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "TAK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=TAK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();